These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12540508)

  • 1. Correspondence re: Zheng et al, Haplotype of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. 11: 640-645, 2002.
    Kumar R; Hemminki K
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):71; author reply 72. PubMed ID: 12540508
    [No Abstract]   [Full Text] [Related]  

  • 2. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Shete S; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):640-5. PubMed ID: 12101111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16(INK4alpha)/exon 2 mutations in squamous cell carcinoma of the head and neck region.
    Lehnerdt G; Fischer M
    Acta Otolaryngol; 2006 Apr; 126(4):414-7. PubMed ID: 16608795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
    J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.
    O'Regan EM; Toner ME; Finn SP; Fan CY; Ring M; Hagmar B; Timon C; Smyth P; Cahill S; Flavin R; Sheils OM; O'Leary JJ
    Hum Pathol; 2008 Mar; 39(3):452-8. PubMed ID: 18261630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck.
    Zhang Z; Shi Q; Wang LE; Sturgis EM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1081-3. PubMed ID: 15184269
    [No Abstract]   [Full Text] [Related]  

  • 9. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
    J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
    Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
    J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.
    Silva JM; Bonilla F
    Cancer Res; 2001 Dec; 61(23):8595-6. PubMed ID: 11731447
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.
    Michiels S; Danoy P; Dessen P; Bera A; Boulet T; Bouchardy C; Lathrop M; Sarasin A; Benhamou S
    Carcinogenesis; 2007 Aug; 28(8):1731-9. PubMed ID: 17494052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K; Schlien S; Bosch FX
    J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of genetic factors in predisposition to squamous cell cancer of the head and neck.
    Jefferies S; Eeles R; Goldgar D; A'Hern R; Henk JM; Gore M
    Br J Cancer; 1999 Feb; 79(5-6):865-7. PubMed ID: 10070882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short hairpin RNA system to inhibit human p16 in squamous cell carcinoma.
    Shin JJ; Katayama T; Michaud WA; Rocco JW
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):68-73. PubMed ID: 14732771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the p16/CDKN2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck.
    Suzuki N; Onda T; Yamamoto N; Katakura A; Mizoe JE; Shibahara T
    Int J Oncol; 2007 Nov; 31(5):1061-7. PubMed ID: 17912431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.